AVITA Medical (RCEL) Invested Capital (2025 - 2026)

AVITA Medical's (RCEL) quarterly Invested Capital came in at $43.0 million in Q4 2025, up 1332.8% on a QoQ basis from $3.0 million in Q3 2025.

AVITA Medical (RCEL) Invested Capital (2025 - 2026) Analysis & Trends

AVITA Medical (RCEL) has 1 years of Invested Capital data on file, last reported at $43.0 million in Q4 2025.

Quarterly Invested Capital changed N/A year-over-year to $43.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $52.0 million (changed N/A YoY) and the FY2025 annual result came in at $43.0 million, changed N/A from the prior year.
Invested Capital rose to $43.0 million in Q4 2025, from $3.0 million in the prior quarter.
In the past five years, Invested Capital ranged from a high of $43.0 million in Q4 2025 to a low of $3.0 million in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	199.44 Bn	193.84 Bn	7.27 Bn	3.01 Bn
2	Stryker	127.32 Bn	123.85 Bn	4.50 Bn	750.00 Mn
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.90 Bn	47.65 Bn	1.35 Bn	-
6	Dexcom	34.30 Bn	32.36 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.74 Bn	31.63 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn	1.34 Bn
9	Steris	23.05 Bn	22.56 Bn	684.20 Mn	243.40 Mn
10	AVITA Medical	311.65 Mn	300.52 Mn	17.77 Mn	46.66 Mn

Download Data